C4 Therapeutics' GAAP loss for 9M 2021 was $68.234 million, up 53.2% from $44.54 million in the prior year. Revenue increased 3.1% to $25.707 million from $24.933 million a year earlier.
C4 Therapeutics' GAAP loss for 9M 2021 was $68.234 million, up 53.2% from $44.54 million in the prior year. Revenue increased 3.1% to $25.707 million from $24.933 million a year earlier. 
ir.c4therapeutics.com
English (US) 